Glioblastoma (GBM) is characterized by aggressive growth and high rates of recurrence.
Despite the advancements in conventional therapies, the prognosis for GBM patients …

Type I interferons have long been appreciated as a cytokine family that regulates antiviral
immunity. Recently, their role in eliciting antitumor immune responses has gained increasing …

Simple Summary Despite multi-modal treatment consisting of surgery, chemotherapy, and
radiation, glioblastoma inevitably recurs due to its diffuse infiltrative nature. Anti-tumor …

Background: Gene therapy can be viewed as a promising/valuable therapeutic approach
directed to cancer treatment, including glioblastoma. Concretely, the combination of gene …

Currently, there is a lack of effective therapies for the majority of glioblastomas (GBMs), the
most common and malignant primary brain tumor. While immunotherapies have shown …

Background High-grade gliomas (HGG) are the most aggressive primary brain tumors with
poor prognoses despite conventional treatments. Immunotherapy has emerged as a …

Mutations in isocitrate dehydrogenase (IDH) are important markers of glioma prognosis.
However, few studies have examined the gene expression regulatory network (GRN) in IDH …

Abstract Background H3 K27M mutated diffuse midline gliomas (DMGs) are extremely
aggressive and the leading cause of cancer‐related deaths in pediatric brain tumors with 5 …

Purpose This study aims to depict the scientific advancements in immunotherapy for glioma
by analyzing the top 100 most frequently cited articles over the past 20 years. Methods The …

Gliomas constitute a diverse and complex array of tumors within the central nervous system
(CNS), characterized by a wide range of prognostic outcomes and responses to therapeutic …